Condition
Microphthalmia
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06293560RecruitingPrimary
Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children
NCT01778543Recruiting
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)
NCT05954403Recruiting
National Cohort on Congenital Defects of the Eye
Showing all 3 trials